Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Other Operating Expenses (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Other Operating Expenses readings, the most recent being $750000.0 for Q1 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $750000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $750000.0, a 81.25% decrease, with the full-year FY2025 number at $750000.0, down 81.25% from a year prior.
  • Other Operating Expenses hit $750000.0 in Q1 2025 for Arcadia Biosciences, down from $4.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.0 million in Q2 2024 to a low of -$5.4 million in Q2 2021.
  • Median Other Operating Expenses over the past 5 years was $58000.0 (2022), compared with a mean of -$66777.8.
  • Biggest five-year swings in Other Operating Expenses: tumbled 106.44% in 2021 and later surged 101.07% in 2022.
  • Arcadia Biosciences' Other Operating Expenses stood at -$480000.0 in 2021, then surged by 85.0% to -$72000.0 in 2022, then surged by 126.39% to $19000.0 in 2023, then surged by 20952.63% to $4.0 million in 2024, then crashed by 81.25% to $750000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $750000.0 (Q1 2025), $4.0 million (Q2 2024), and $19000.0 (Q1 2023) per Business Quant data.